Clinical information regarding cells from patients with newly diagnosed precursor-B ALL
Patient no. . | Source . | % Blasts . | Immunophenotype . | Molecular data . |
|---|---|---|---|---|
| 1 | PB | 95 | c-ALL | BCR/ABL negative, MLL/AF4 negative, TEL/AML 1 negative |
| 2 | PB | 93 | Pro-BALL | t(4;11), BCR/ABL negative, MLL/AF4 positive, TEL/AML 1 negative, MLL/ENL negative |
| 3 | BM | 92.5 | c-ALL | BCR/ABL negative, MLL/AF4 negative, TEL/AML 1 negative |
| 4 | PB | 95 | c-ALL | BCR/ABL negative, MLL/AF4 negative, TEL/AML 1 negative |
| 5 | BM | 100 | c-ALL | t(12;21) |
| 6 | PB | 70 | Pro-BALL | t(4;11) |
Patient no. . | Source . | % Blasts . | Immunophenotype . | Molecular data . |
|---|---|---|---|---|
| 1 | PB | 95 | c-ALL | BCR/ABL negative, MLL/AF4 negative, TEL/AML 1 negative |
| 2 | PB | 93 | Pro-BALL | t(4;11), BCR/ABL negative, MLL/AF4 positive, TEL/AML 1 negative, MLL/ENL negative |
| 3 | BM | 92.5 | c-ALL | BCR/ABL negative, MLL/AF4 negative, TEL/AML 1 negative |
| 4 | PB | 95 | c-ALL | BCR/ABL negative, MLL/AF4 negative, TEL/AML 1 negative |
| 5 | BM | 100 | c-ALL | t(12;21) |
| 6 | PB | 70 | Pro-BALL | t(4;11) |
PB indicates peripheral blood.